Adaptive Biotechnologies Corporation

ADPT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$23.11+2.39%

2026-08-03

Financials

Valuation Metrics

Adaptive Biotechnologies Corporation's Market Cap is $3.70B. At end of 2025 it was $2.49B. Ranked #1620 of 3,112 in US market (top 52%), #570 of 1,445 on NASDAQ (top 39%), #92 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 34%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$3.70B	US#1,620/3,112 Sec#92/269
Revenue	$295M	US#2,566/3,112 Sec#99/269
Net Income	$-50M	US—/3,112 Sec—/269
Total Assets	$506M	US#2,737/3,112 Sec#154/269
Net Assets	$216M	US#2,712/3,112 Sec#192/269
Value
P/B	17.10x	US#2,772/3,112 Sec#225/269
P/S	12.52x	US#2,715/3,112 Sec#128/269
FCF Yield	-0.80%	US—/3,112 Sec—/269
Profitability
ROE	-22.96%	US#2,557/3,112 Sec#109/269
ROA	-9.82%	US#2,641/3,112 Sec#101/269
Op. Margin	-15.82%	US#2,676/3,112 Sec#104/269
Revenue Growth	35.14%	US#426/3,112 Sec#66/269
Financial Health
Debt Ratio	130.21%	US#1,337/3,112 Sec#177/269
Total Debt	$208M	US#2,175/3,112 Sec#90/269
FCF	$-30M	US#2,408/3,112 Sec#101/269
Cash	$78M	US#2,356/3,112 Sec#194/269
Current Ratio	3.35x	US#698/3,112 Sec#183/269
Performance
1Y Return	123.72%	US#255/3,112 Sec#69/269
1M Return	9.06%	US#601/3,112 Sec#28/269
From 52W High	-5.94%	US#650/3,112 Sec#25/269
1Y MDD	-39.35%	US#1,916/3,112 Sec#142/269
Trading
Volume	2,222,332 shares	US#816/3,112 Sec#73/269
Trading Value	$51M	US#1,342/3,112 Sec#82/269
Per Share
EPS	$-0.39	US—/3,112 Sec—/269
BPS	$1.43	US#2,571/3,112 Sec#189/269